Guy Fournet

Saint-priest-la-vetre, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Resorufin-derived esters as fluorescent probes to test for the esterase activity and active-site topology of aldehyde dehydrogenase.

Resorufin-derived esters as fluorescent probes to test for the esterase activity and active-site topology of aldehyde dehydrogenase.

Journal: Chemico-biological interactions

Published: March 16, 2026

Scout-triggered MRM from untargeted data: An R-based strategy for multiplexed targeted metabolomics.

Scout-triggered MRM from untargeted data: An R-based strategy for multiplexed targeted metabolomics.

Journal: Talanta

Published: January 09, 2026

Inter- and intra-tumoral ALDH1 heterogeneity in breast cancer identifies therapeutic opportunities for ALDH1A-specific inhibitors.

Inter- and intra-tumoral ALDH1 heterogeneity in breast cancer identifies therapeutic opportunities for ALDH1A-specific inhibitors.

Journal: Cell chemical biology

Published: February 27, 2025

Identifying Potent Nonsense-Mediated mRNA Decay Inhibitors with a Novel Screening System.

Identifying Potent Nonsense-Mediated mRNA Decay Inhibitors with a Novel Screening System.

Journal: Biomedicines

Published: September 18, 2023

Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform.

Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: February 14, 2021

Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer.

Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer.

Journal: Oncogene

Published: July 19, 2019

Monodisperse polysarcosine-based highly-loaded antibody-drug conjugates.

Monodisperse polysarcosine-based highly-loaded antibody-drug conjugates.

Journal: Chemical science

Published: January 17, 2019

Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes.

Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes.

Journal: Nature communications

Published: April 18, 2017

ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.

ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.

Journal: Oncogene

Published: October 18, 2016

Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors.

Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors.

Journal: Blood cancer journal

Published: July 29, 2016

Targeting Integrin-Dependent Adhesion and Signaling with 3-Arylquinoline and 3-Aryl-2-Quinolone Derivatives: A new Class of Integrin Antagonists.

Targeting Integrin-Dependent Adhesion and Signaling with 3-Arylquinoline and 3-Aryl-2-Quinolone Derivatives: A new Class of Integrin Antagonists.

Journal: PloS one

Published: June 23, 2015

Synthesis and biological evaluation of tetrahydro[1,4]diazepino[1,2-a]indol-1-ones as cyclin-dependent kinase inhibitors.

Synthesis and biological evaluation of tetrahydro[1,4]diazepino[1,2-a]indol-1-ones as cyclin-dependent kinase inhibitors.

Journal: European journal of medicinal chemistry

Published: April 07, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026